Cannabinoids Market Projected To Surpass $120.56 Billion By 2030 At 20.7% CAGR

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Size Of The Cannabinoids Market Progress Through 2030?

The cannabis extract market size has witnessed substantial growth in recent years. It is projected to expand from $12.6 billion in 2025 to $15.13 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 20.1%. This historical growth can be attributed to the increasing legalization of hemp-derived products, a rising consumer demand for natural therapeutics, the expansion of CBD oil production, the proliferation of cosmetic ingredient applications, and the availability of commercial extraction technologies.

The cannabis extract market size is anticipated to undergo significant expansion in the coming years. It is projected to achieve a value of $30.83 billion by 2030, growing at a compound annual growth rate (CAGR) of 19.5%. This growth throughout the forecast period can be ascribed to the increasing pharmaceutical application of cannabis extracts, heightened investments in GMP-compliant extraction facilities, the expansion of regulated cannabis product markets, a rising demand for high-purity extracts, and greater integration into wellness and personal care products. Prominent trends for the forecast period include a growing demand for full-spectrum cannabis extracts, the increasing utilization of cannabis extracts in pharmaceuticals, their rising adoption in cosmetic and wellness products, the proliferation of standardized extraction processes, and enhanced quality control and traceability.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8079&type=smp

Which Core Factors Are Supporting The Expansion Of The Cannabinoids Market?

The rising occurrence of cancer is anticipated to drive the expansion of the cannabis extract market in the future. Cancer is defined as a condition where certain body cells multiply uncontrollably and disseminate to various parts of the body. Cannabis extract is beneficial in managing symptoms like neuropathy, nausea, pain, vomiting, appetite issues, and weight loss in individuals with cancer. It influences cancer progression by promoting autophagy and modulating signaling pathways that lead to apoptosis. For example, data from May 2024 by the National Institutes of Health, a US-based Government agency, indicates that in 2024, an estimated 2,001,140 new cancer cases will be identified in the United States, with 611,720 fatalities attributed to the illness. Consequently, the growing incidence of cancer serves as a significant impetus for the expansion of the cannabis extract market.

How Does Segment Analysis Break Down The Cannabinoids Market Structure?

The cannabinoids market covered in this report is segmented –

1) By Product Type: Cannabidiol, Tetrahydrocannabinol, Cannabinol, Other Product Types

2) By Distribution: Hospital Pharmacies, Retail Pharmacies, Online Stores

3) By Application: Medical, Recreational, Industrial Hemp

Subsegments:

1) By Cannabidiol (CBD): Full-Spectrum CBD, Broad-Spectrum CBD, CBD Isolate

2) By Tetrahydrocannabinol (THC): Delta-9 THC, Delta-8 THC

3) By Cannabinol (CBN): CBN Isolate, CBN Oil

4) By Other Product Types: Cannabigerol (CBG), Cannabichromene (CBC)

What Trends Are Influencing The Cannabinoids Market Outlook?

Leading companies in the cannabis extract market are prioritizing the development of innovative solutions, including medical cannabis oil products, to address the growing demand across both therapeutic and wellness sectors. Medical cannabis oil products refer to oils sourced from the cannabis plant containing active cannabinoids such as cannabidiol (CBD) and tetrahydrocannabinol (THC), which are used for medicinal purposes. For instance, in May 2024, Stenocare A/S, a pharmaceutical company based in Denmark, unveiled its advanced medical cannabis oil product, Astrum 10-10, having secured regulatory approval for sales in Australia and Germany. This groundbreaking product is designed to establish new pharmaceutical-grade standards for effectiveness and potency within medical cannabis. This launch is integral to STENOCARE’s wider strategy to improve patient access to high-quality prescription-based medical cannabis. The initial sales of this product are projected for Q4 2024, reflecting STENOCARE’s dedication to product innovation and market expansion in the dynamic medical cannabis environment.

Who Are The Companies Shaping The Cannabinoids Market Landscape?

Major companies operating in the cannabinoids market are The Supreme Cannabis Company Inc., Elixinol Global Limited, GW Pharmaceuticals PLC, Tilray Inc., Aurora Cannabis Inc., Curaleaf Holdings Inc., Green Thumb Industries, Verano Holdings, Trulieve Cannabis Corp., Cresco Labs Inc., Cronos Group, TerrAscend Corp., Canopy Growth Corp., Sundial Growers Inc., Decibel Cannabis Company, Auxly Cannabis Group, Red White & Bloom Brands, BZAM Ltd, Delta 9 Cannabis Inc., Jazz Pharmaceuticals PLC, Aphria Inc., Organigram Inc., MediPharm Labs Corp., The Valens GroWorks Inc.

Access The Complete Cannabinoids Market Report:

https://www.thebusinessresearchcompany.com/report/cannabinoids-global-market-report

Which Region Leads The Cannabinoids Market By Size?

North America was the largest region in the cannabinoids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cannabinoids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Cannabinoids Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=8079&type=smp

Browse Through More Reports Similar to the Global Cannabinoids Market 2026, By The Business Research Company

Yeast Infection Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/yeast-infection-treatment-global-market-report

Systemic Aspergillosis And Systemic Candidiasis Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/systemic-aspergillosis-and-systemic-candidiasis-global-market-report

Antifungals Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/antifungals-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795